Literature DB >> 7614644

Granisetron-dexamethasone combination reduces postoperative nausea and vomiting.

Y Fujii1, H Tanaka, H Toyooka.   

Abstract

The prophylactic antiemetic efficacy of combined granisetron and dexamethasone was evaluated in a randomized double-blind manner in 88 patients undergoing general anaesthesia for major gynaecological surgery. Immediately after recovery from anaesthesia, patients received a single dose of either placebo (saline, n = 22), granisetron (20 micrograms.kg-1, n = 22), dexamethasone (8 mg, n = 22) or combined granisetron and dexamethasone (20 micrograms.kg-1 and 8 mg, respectively, n = 22) iv. The treatment groups were similar for patient demography, surgical procedures, anaesthetics administered and opioids given. Postoperatively, the frequency of nausea was 32%, 23%, 27% and 5% after administration of placebo, granisetron, dexamethasone and granisetron plus dexamethasone, respectively; the corresponding frequencies of vomiting were 23%, 23%, 23% and 5%. The incidence of adverse events postoperatively were not different among the groups. It is concluded that prophylactic administration of combined granisetron and dexamethasone is effective in preventing postoperative nausea and vomiting after anaesthesia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7614644     DOI: 10.1007/BF03015482

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  8 in total

1.  Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy.

Authors:  D B Smith; E S Newlands; G J Rustin; R H Begent; N Howells; B McQuade; K D Bagshawe
Journal:  Lancet       Date:  1991-08-24       Impact factor: 79.321

2.  A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation with anti-emetic response.

Authors:  J Carmichael; B M Cantwell; C M Edwards; B D Zussman; S Thompson; W G Rapeport; A L Harris
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 3.  Postoperative nausea and vomiting. Its etiology, treatment, and prevention.

Authors:  M F Watcha; P F White
Journal:  Anesthesiology       Date:  1992-07       Impact factor: 7.892

4.  Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide.

Authors:  M S Aapro; P M Plezia; D S Alberts; V Graham; S E Jones; E A Surwit; T E Moon
Journal:  J Clin Oncol       Date:  1984-05       Impact factor: 44.544

5.  Antiemetic effectiveness of intramuscular hydroxyzine compared with intramuscular droperidol.

Authors:  R McKenzie; R K Wadhwa; N T Uy; P Phitayakorn; B Tantisira; C Sinchioco; F H Taylor
Journal:  Anesth Analg       Date:  1981-11       Impact factor: 5.108

6.  Optimal anti-emetic dose of granisetron for preventing postoperative nausea and vomiting.

Authors:  Y Fujii; H Tanaka; H Toyooka
Journal:  Can J Anaesth       Date:  1994-09       Impact factor: 5.063

7.  Reduction of postoperative nausea and vomiting with granisetron.

Authors:  Y Fujii; H Tanaka; H Toyooka
Journal:  Can J Anaesth       Date:  1994-04       Impact factor: 5.063

8.  The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694.

Authors:  J Bermudez; E A Boyle; W D Miner; G J Sanger
Journal:  Br J Cancer       Date:  1988-11       Impact factor: 7.640

  8 in total
  4 in total

1.  Ondansetron, metoclopramid, dexamethason, and their combinations compared for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a prospective randomized study.

Authors:  K Leksowski; P Peryga; R Szyca
Journal:  Surg Endosc       Date:  2006-05-11       Impact factor: 4.584

Review 2.  Prevention and treatment of postoperative nausea and vomiting.

Authors:  A L Kovac
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

Review 3.  Benefits and risks of newer treatments for chemotherapy-induced and postoperative nausea and vomiting.

Authors:  Anthony L Kovac
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

4.  Granistron and dexamethasone provide more improved prevention of postoperative emesis than granisetron alone in children.

Authors:  Y Fujii; H Tanaka; H Toyooka
Journal:  Can J Anaesth       Date:  1996-12       Impact factor: 5.063

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.